Search for content, post, videos

Personalized therapy for severe lupus

Tara Heitner ISD Immunotech
ISD Immunotech expects to finalize characterization of its STING antagonist lead candidate this year, aiming to develop the first personalized treatment for severe lupus patients. Systemic lupus erythematous (SLE) is a complex and hard-to-treat autoimmune disease with a high unmet medical need. I
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.

1 comment